Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · IEX Real-Time Price · USD

0.692

-0.023 (-3.25%)

At close: Apr 18, 2024, 4:00 PM

0.730

+0.038 (5.54%)

After-hours: Apr 18, 2024, 7:46 PM EDT

Atara Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	8.57	63.57	20.34	0	0	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	-86.51%	212.55%	-	-	-	-	-	-	-	-	Upgrade
Cost of Revenue	8.89	0	0	0	0	0	0	0	0	0	Upgrade
Gross Profit	-0.31	63.57	20.34	0	0	0	0	0	0	0	Upgrade
Selling, General & Admin	50.91	71.55	78.8	64.4	79.58	69.65	40.33	24.73	16.83	12.71	Upgrade
Research & Development	224.79	272.53	282	244.65	216.1	167.46	81.21	56.51	41.62	15.45	Upgrade
Operating Expenses	275.69	344.09	360.8	309.05	295.68	237.11	121.53	81.24	58.45	28.16	Upgrade
Operating Income	-276.01	-280.51	-340.46	-309.05	-295.68	-237.11	-121.53	-81.24	-58.45	-28.16	Upgrade
Interest Expense / Income	5.29	0.37	-0.37	-2.45	-4.72	-6.37	-2.03	-2.2	-1.22	-0.13	Upgrade
Other Expense / Income	-5.18	-52.6	-	-	-	-	-	-	-	-	Upgrade
Pretax Income	-276.11	-228.29	-340.1	-306.61	-290.96	-230.74	-119.51	-79.04	-57.23	-28.03	Upgrade
Income Tax	0.02	0.01	0.05	0.02	0.01	-0.04	-0.01	0.01	-0.01	-0.03	Upgrade
Net Income	-276.13	-228.3	-340.14	-306.62	-290.98	-230.7	-119.49	-79.05	-57.22	-28.01	Upgrade
Shares Outstanding (Basic)	106	102	94	74	51	44	30	29	26	5	Upgrade
Shares Outstanding (Diluted)	106	102	94	74	51	44	30	29	26	5	Upgrade
Shares Change	3.85%	8.88%	26.63%	44.17%	17.11%	46.71%	3.94%	12.31%	413.10%	416.24%	Upgrade
EPS (Basic)	-2.61	-2.24	-3.63	-4.15	-5.67	-5.27	-4.00	-2.75	-2.24	-5.62	Upgrade
EPS (Diluted)	-2.61	-2.24	-3.63	-4.15	-5.67	-5.27	-4.00	-2.75	-2.24	-5.62	Upgrade
Free Cash Flow	-194.18	-179.86	-231.1	-185.27	-241.2	-215.7	-107.73	-63.05	-37.45	-16.67	Upgrade
Free Cash Flow Per Share	-1.83	-1.76	-2.47	-2.50	-4.70	-4.92	-3.61	-2.19	-1.46	-3.34	Upgrade
Gross Margin	-3.65%	100.00%	100.00%	-	-	-	-	-	-	-	Upgrade
Operating Margin	-3219.48%	-441.25%	-1673.85%	-	-	-	-	-	-	-	Upgrade
Profit Margin	-3220.88%	-359.12%	-1672.28%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-2264.96%	-282.92%	-1136.19%	-	-	-	-	-	-	-	Upgrade
EBITDA	-254.2	-213.35	-329.17	-299.26	-287.65	-233.38	-120.58	-80.86	-58.4	-28.15	Upgrade
EBITDA Margin	-2965.15%	-335.60%	-1618.33%	-	-	-	-	-	-	-	Upgrade
Depreciation & Amortization	16.62	14.57	11.29	9.79	8.03	3.73	0.96	0.38	0.05	0.01	Upgrade
EBIT	-270.83	-227.92	-340.46	-309.05	-295.68	-237.11	-121.53	-81.24	-58.45	-28.16	Upgrade
EBIT Margin	-3159.06%	-358.51%	-1673.85%	-	-	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).